{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:35:15Z","timestamp":1789990515619,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3446,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1038\/sj.ki.5001528","type":"journal-article","created":{"date-parts":[[2006,5,10]],"date-time":"2006-05-10T15:25:01Z","timestamp":1147274701000},"page":"97-103","source":"Crossref","is-referenced-by-count":70,"title":["Imatinib ameliorates renal disease and survival in murine lupus autoimmune disease"],"prefix":"10.1016","volume":"70","author":[{"given":"C.","family":"Zoja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Corna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Rottoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Zanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Abbate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/sj.ki.5001528_bb0010","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0065-2776(08)60444-7","article-title":"The immunology and pathology of NZB mice","volume":"9","author":"Howie","year":"1968","journal-title":"Adv Immunol"},{"key":"10.1038\/sj.ki.5001528_bb0015","first-page":"12","article-title":"Relevance of systemic lupus erythematosus nephritis animal models to human disease","volume":"19","author":"Foster","year":"1999","journal-title":"Semin Nephrol"},{"key":"10.1038\/sj.ki.5001528_bb0020","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1053\/S0270-9295(03)00135-9","article-title":"Recent advances in the pathogenesis of lupus nephritis: autoantibodies and B cells","volume":"23","author":"Su","year":"2003","journal-title":"Semin Nephrol"},{"key":"10.1038\/sj.ki.5001528_bb0025","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00041552-199905000-00005","article-title":"Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis","volume":"8","author":"Berden","year":"1999","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1038\/sj.ki.5001528_bb0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00041552-200205000-00002","article-title":"Immunopathogenesis of lupus and lupus nephritis: recent insights","volume":"11","author":"Kewalramani","year":"2002","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1038\/sj.ki.5001528_bb0035","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0272-6386(12)80741-4","article-title":"Immunosuppressive drug therapy in lupus nephritis","volume":"21","author":"Donadio","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001528_bb0040","doi-asserted-by":"crossref","first-page":"22375","DOI":"10.1016\/S0021-9258(18)54582-8","article-title":"In vivo and in vitro inhibition of JE gene expression by glucocorticoids","volume":"266","author":"Poon","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.ki.5001528_bb0045","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/art.1780390906","article-title":"Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus","volume":"39","author":"Pryor","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1038\/sj.ki.5001528_bb0050","first-page":"527","article-title":"Treatment of lupus nephritis","volume":"16","author":"Austin","year":"1996","journal-title":"Semin Nephrol"},{"key":"10.1038\/sj.ki.5001528_bb0055","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/ki.1997.217","article-title":"Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease","volume":"51","author":"Corna","year":"1997","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001528_bb0060","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1046\/j.1523-1755.2001.060002653.x","article-title":"Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis","volume":"60","author":"Zoja","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001528_bb0065","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.V981407","article-title":"Attenuation of murine lupus nephritis by mycophenolate mofetil","volume":"9","author":"van Bruggen","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001528_bb0070","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1046\/j.1523-1755.1998.00804.x","article-title":"Bindarit retards renal disease and prolongs survival in murine lupus autoimmune disease","volume":"53","author":"Zoja","year":"1998","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001528_bb0075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/0961203305lu2064oa","article-title":"Novel therapies in lupus nephritis","volume":"14","author":"Tahir","year":"2005","journal-title":"Lupus"},{"key":"10.1038\/sj.ki.5001528_bb0080","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1111\/j.1523-1755.2005.00266.x","article-title":"Treatment of glomerulonephritis: will we ever have options other than steroids and cytotoxics?","volume":"67","author":"Javaid","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001528_bb0085","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.ph.57.030195.001501","article-title":"Role of platelet-derived growth factor in renal injury","volume":"57","author":"Abboud","year":"1995","journal-title":"Annu Rev Physiol"},{"key":"10.1038\/sj.ki.5001528_bb0090","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1152\/physrev.1999.79.4.1283","article-title":"Mechanism of action and in vivo role of platelet-derived growth factor","volume":"79","author":"Heldin","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1038\/sj.ki.5001528_bb0095","first-page":"271","article-title":"Multiple roles for platelet-derived growth factor in renal disease","volume":"21","author":"Floege","year":"1995","journal-title":"Miner Electrolyte Metab"},{"key":"10.1038\/sj.ki.5001528_bb0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0090-1229(92)90010-L","article-title":"Renal platelet-derived growth factor gene expression in NZB\/W F1 mice with lupus and ddY mice with IgA nephropathy","volume":"63","author":"Nakamura","year":"1992","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1038\/sj.ki.5001528_bb0105","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1365-2249.1997.d01-970.x","article-title":"Calorie restriction decreases platelet-derived growth factor (PDGF)-A and thrombin receptor mRNA expression in autoimmune murine lupus nephritis","volume":"108","author":"Troyer","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/sj.ki.5001528_bb0110","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000190253","article-title":"Expression of platelet-derived growth factor in lupus nephritis in MRL\/MpJ-1pr\/1pr mice","volume":"77","author":"Entani","year":"1997","journal-title":"Nephron"},{"key":"10.1038\/sj.ki.5001528_bb0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000169067","article-title":"Gene expression of PDGF and PDGF receptor in various forms of glomerulonephritis","volume":"17","author":"Matsuda","year":"1997","journal-title":"Am J Nephrol"},{"key":"10.1038\/sj.ki.5001528_bb0120","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1681\/ASN.V125909","article-title":"Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis","volume":"12","author":"Ostendorf","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001528_bb0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/med.10028","article-title":"Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease","volume":"23","author":"Kurogi","year":"2003","journal-title":"Med Res Rev"},{"key":"10.1038\/sj.ki.5001528_bb0130","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat Med"},{"key":"10.1038\/sj.ki.5001528_bb0135","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","article-title":"The development of imatinib as a therapeutic agent for chronic myeloid leukemia","volume":"105","author":"Deininger","year":"2005","journal-title":"Blood"},{"key":"10.1038\/sj.ki.5001528_bb0140","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1046\/j.1523-1755.2001.0590041324.x","article-title":"PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis","volume":"59","author":"Gilbert","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001528_bb0145","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1681\/ASN.2004050392","article-title":"Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice","volume":"16","author":"Lassila","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 1","key":"10.1038\/sj.ki.5001528_bb0150","first-page":"S65","article-title":"Imatinib mesylate (Glivec, Gleevec) in the treatment of chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GIST)","volume":"83","author":"Hochhaus","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1038\/sj.ki.5001528_bb0155","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1182\/blood-2004-01-0246","article-title":"Imatinib targets other than bcr\/abl and their clinical relevance in myeloid disorders","volume":"104","author":"Pardanani","year":"2004","journal-title":"Blood"},{"key":"10.1038\/sj.ki.5001528_bb0160","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4615-0081-0_12","article-title":"Targeting PDGF receptors in cancer \u2013 rationales and proof of concept clinical trials","volume":"32","author":"George","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1038\/sj.ki.5001528_bb0165","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1681\/ASN.V85720","article-title":"Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice","volume":"8","author":"Zoja","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001528_bb0170","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1172\/JCI114519","article-title":"Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes","volume":"85","author":"Siegbahn","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5001528_bb0175","first-page":"1169","article-title":"Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis","volume":"148","author":"Tang","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1038\/sj.ki.5001528_bb0180","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0002-9440(10)64265-4","article-title":"Independent regulation of transforming growth factor-beta1 transcription and translation by glucose and platelet-derived growth factor","volume":"161","author":"Fraser","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1038\/sj.ki.5001528_bb0185","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1172\/JCI200419603","article-title":"Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis","volume":"114","author":"Daniels","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5001528_bb0190","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1182\/blood-2003-12-4266","article-title":"Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo","volume":"104","author":"Dietz","year":"2004","journal-title":"Blood"},{"key":"10.1038\/sj.ki.5001528_bb0195","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/sj.leu.2403401","article-title":"Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro","volume":"18","author":"Cwynarski","year":"2004","journal-title":"Leukemia"},{"key":"10.1038\/sj.ki.5001528_bb0200","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1182\/blood-2004-07-2527","article-title":"Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner","volume":"105","author":"Seggewiss","year":"2005","journal-title":"Blood"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815517638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815517638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T02:19:24Z","timestamp":1627352364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815517638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0085253815517638"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5001528","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}